Related Experiment Video

Updated: Jul 20, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Adenoviral gene therapy in head and neck cancer

Emanuela Vattemi1, Pier Paolo Claudio

  • 1Department of Clinical and Experimental Medicine, Section of Medical Oncology, University of Verona, Verona, Italy.

Drug News & Perspectives
|September 15, 2006
PubMed

Insights

Adenoviruses show promise for head and neck cancer treatment, offering new gene therapy options. This review explores adenovirus-mediated p53 gene therapy and the oncolytic adenovirus ONYX-015 in clinical trials.

Area of Science:

  • Oncology
  • Virology
  • Gene Therapy

Background:

  • Head and neck cancer treatment has seen limited survival improvements despite advances in surgery, radiation, and chemotherapy.
  • Understanding cancer biology reveals molecular pathways as potential therapeutic targets.
  • Adenoviruses are emerging as key tools for developing these molecular therapies.

Purpose of the Study:

  • To review the use of adenoviruses in head and neck cancer therapy.
  • To examine clinical trials of adenovirus-mediated p53 gene therapy.
  • To assess the application of the oncolytic adenovirus ONYX-015.

Main Methods:

  • Review of clinical trials involving adenovirus-mediated gene therapy for head and neck cancer.
  • Examination of the efficacy and application of ONYX-015 in head and neck cancer treatment.
  • Analysis of adenovirus as a vector for gene delivery in cancer therapy.

Main Results:

  • Adenoviruses are being engineered as vectors for gene therapy delivery.
  • Clinical trials are investigating adenovirus-mediated p53 gene therapy.
  • The oncolytic adenovirus ONYX-015 shows potential in head and neck cancer applications.

Conclusions:

  • Targeting molecular pathways in head and neck cancer offers new therapeutic avenues.
  • Adenoviruses represent a significant advancement in developing these molecular approaches.
  • Adenovirus-based therapies, including gene therapy and oncolytic virotherapy, hold promise for improving head and neck cancer treatment outcomes.

More Related Videos

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models06:16

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction04:43

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction

Published on: October 11, 2024

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.